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Abstract
Background: The aim of this study was to investigate the effect of cardiac resynchronization 
therapy (CRT) with right ventricular (RV) sense triggered left ventricular (LV) pacing for 
chronic heart failure (CHF).
Methods: Thirty patients who were eligible for the Class I indication of CRT were enrolled 
and the informed consents were signed. Left ventricular ejection fraction (LVEF), diastolic 
mitral flow velocity time integral (VTI), mitral regurgitation flow VTI, and aortic valve flow 
VTI were measured with GE Vivid 7 (GE Medical, Milwaukee, WI, USA) before and after 
CRT. The echocardiographic measurements and the average annual costs of the device use 
were compared.
Results: The duration of QRS complex, the length of time used for optimization, and the 
average annual cost of the device use under RV sense triggered LV pacing were significantly 
less than that under standard biventricular (BiV) pacing (p < 0.01), while the average battery 
lifetime was longer. Subgroup analysis showed that LVEF, diastolic mitral flow VTI, and aortic 
valve flow VTI under RV sense triggered LV pacing were greater than that under standard BiV 
pacing with right or LV pre-activation. The average battery lifetime was significantly longer 
and the average annual cost of the device use was less. The mitral regurgitation flow VTI 
under RV sense triggered LV pacing was less than that under standard BiV pacing with RV 
pre-activation.
Conclusions: RV sense triggered LV provides benefits for CHF patients over standard CRT 
in terms of maintaining the physiological atrio-ventricular delay of atrio-ventricular node and 
improving the acute hemodynamic effects. (Cardiol J 2015; 22, 1: 80–86)
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Introduction
Chronic heart failure (CHF) is a common 
disease with a high mortality in the patients with 
CHF. Treatment of CHF has met some difficulty, 
especially at significant expense [1]. Conduction 
abnormalities, such as left bundle branch block 
(LBBB), frequently co-exist in patients with CHF 
[2]. LBBB, which manifests as dyssynchronization 
of left ventricle (LV) and right ventricle (RV), delay 
of LV contraction, and paradoxical movement of 
ventricular septum decreases the effective cardiac 
output [3].
By setting a relative shorter atrioventricular 
(AV) interval and an appropriate interventricular 
(VV) interval, cardiac resynchronization therapy 
(CRT) might realize AV and VV synchronization, 
mitigate mitral regurgitation, extend the time for 
ventricular filling, and restore the contribution of 
atrial contraction to LV filling. Furthermore, CRT 
can alleviate symptoms, reduce the rate of hospi-
talization, and significantly decrease mortality 
[4–6]. However, approximately 30% of patients 
remain non-responsive to CRT [7–9]. This phe-
nomenon can be partly caused by the fixed short 
AV delay (AVD), which abolishes the physiological 
AVD of AV node (AVN), resulting in detrimental 
effects on cardiac structure and function. These 
may counteract the benefit of CRT. Therefore, 
setting appropriate AVD to maintain the physio-
logical AVD of AVN and promote the conduction 
through the right His-Purkinje system, and pa-
cing LV simultaneously might more better than 
standard biventricular (BiV) pacing. This study 
will evaluate the effect of RV sense triggered LV 
pacing, and compare it with standard BiV pacing.
Methods
Patients
Enrollment criteria. From September 2007 
to September 2010, 30 CHF patients (7 females 
and 23 males) with LBBB, who were eligible for 
CRT implantation due to class I indication [8], were 
enrolled into this cross-over study at the First 
Affiliated Hospital of Kunming Medical Univer-
sity. The informed consents for the implantation 
of pacemaker or defibrillator with CRT function 
(INSYNC III 8042 CRT-P, INSYNC III PROTECT 
7285 CRT-D, INSYNC MAXIMO 7304 CRT-D, 
and INSYNC SENTRY 7298 CRT-D, all produced 
by Metronic in USA) were obtained. The criteria 
of enrollment were: (i) ischemic or non-ischemic 
cardiomyopathy; (ii) New York Heart Association 
Class III or ambulatory Class IV after optimal me-
dical therapy for CHF; (iii) sinus rhythm; (iv) left 
ventricular ejection fraction (LVEF) £ 35%, and 
(v) QRS ≥ 120 ms. All the enrolled patients were 
given standard medical therapy for CHF, including 
beta receptor antagonist, angiotensin converting 
enzyme inhibitors or angiotensin II receptor bloc-
ker, and spironolactone.
Exclusion criteria. Standards are as follows: 
(i) survival expectancy less than 1 year; (ii) car-
diomyopathy due to reversible causes; (iii) valve 
diseases that have not addressed by surgery; 
(iv) hypertrophic obstructive cardiomyopathy; 
(v) right bundle branch block, and (vi) second or 
third degree AV block; (vii) PQ interval > 0.22 s.
Measurements
Measurement of QRS duration. The elec-
trocardiogram (ECG) data were recorded by MAR-
QUET 12-lead ECG machine (GE, USA, speed: 25 
mm/s; gain: 1 mV/10 mm) before and after CRT 
(optimizing with current guideline and activating 
RV sense triggered LV pacing respectively). The 
QRS duration was automatically calculated by the 
machine.
Measurement of cardiac ultrasound in-
dicators. The echocardiographic measurements 
were performed by a technician who was not aware 
of the group of patients. Firstly, LV end-diastolic 
diameter was assessed by Vivid 7 Color Doppler 
System (GE, USA, 2.5 MHz, Vivid 7). Secondly, 
diastolic mitral spectrum of blood flow was recor-
ded with sample volume (pulse Doppler) on the 
level of mitral ostium under apex 4-chamber view. 
Thirdly, LV outflow tract spectrum of blood flow 
was recorded with sample volume (pulse Doppler) 
located 0.5 cm below the level of aortic valve under 
apex 5-chamber view. The following indicators 
were evaluated before and after CRT (optimizing 
with current guideline and activating RV sense 
triggered LV pacing, respectively) in each patient: 
(i) LVEF; (ii) diastolic mitral velocity time integral 
(VTI) and mitral regurgitation VTI, and (iii) aortic 
valve VTI. Each indicator was assessed 3 times 
and an average was calculated.
AV and VV interval optimization with 
traditional method. AV and VV intervals were 
optimized after CRT implantation. The optimal 
AVD was defined as the shortest AVD which could 
ensure the longest duration of ventricular filling, 
the largest stroke volume, and the minimization 
of mitral regurgitation. The pacing mode was pro-
grammed to BiV pacing (RV + LV) and the AVD 
was titrated. If the function of sinus node of the 
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patient was normal, then sensed AV interval was 
used. If the percentage of atrial pacing was greater 
than 50%, then the paced AV interval was used. 
The aortic spectrum of blood flow was recorded 
under apex 5-chamber view and the aortic VTI was 
calculated. The optimal AV interval was confirmed 
when the largest aortic VTI, the minimization of 
mitral regurgitation, the longest duration of ven-
tricular filling, and the highest peak of separated 
intact E and A wave were accomplished [10, 11]. 
VV interval was optimized after the AV interval 
optimization was completed. The optimal VV in-
terval was confirmed when the largest aortic VTI 
was accomplished [12–14]. The cardiac function 
corresponding to each AV interval was calculated 
5 min after the AV interval was titrated. The echo-
cardiographic measurements of each patient were 
recorded after the AV interval and the VV intervals 
were optimized.
The programming of RV sense triggered 
LV pacing. The electrogram marker channel and 
the ECG were showed on the programmer (9790, 
Medtronic, USA). The AVD was extended step 
by step until ventricular sense showed upon the 
marker channel. The pacing mode was program-
med to LV-only, meanwhile, the ventricular sense 
reaction (VSR) was set to ON, i.e. activating RV 
sense triggered LV pacing. LVEF, diastolic mitral 
VTI, mitral regurgitation VTI, and aortic VTI were 
assessed 5 min later. The optimal AV and VV inter-
vals were restored after the previously mentioned 
measurements were completed. The time (minute 
as unit) for optimizing the 2 different CRT pacing 
modes was recorded respectively.
Estimate of the battery lifetime. The 
battery lifetime was estimated under standard 
BiV pacing and RV sense triggered LV pacing, 
respectively. The minimal, maximal, and average 
battery lifetimes were automatically calculated by 
the system. The average annual cost of the device 
use was calculated according to the cost of CRT 
device and the estimated battery lifetime.
Data analysis 
All data were analyzed with SPSS 13.0 soft-
ware. Continuous variables were expressed as 
mean and standard deviation. Data in the three 
groups were compared with variance analysis 
(Dunnet’s test was used if variance was not homo-
geneous). The means in two groups were compared 
with t test if the data were conformed as normal 
distribution; if not, Mann-Whitney U test was used. 
P < 0.05 was considered statistically significant.
Results
The duration of QRS complex (131.45 ± 7.48 ms), 
the length of time used for optimization (10.79 ± 
± 4.02 min), and the average annual cost of the 
device use under RV sense triggered LV pacing 
[mean 13800 (13100–14500) Ren Min Bi (RMB)] 
were significantly lower than those under standard 
BiV pacing (139.76 ± 11.73 ms, 55.6 ± 8.77 min, 
and mean 21200 (20400–22000) RMB, respectively 
(p < 0.01).
The comparison of measurements prior to 
CRT, standard BiV and pacing RV sense triggered 
LV pacing treatment was displayed in Table 1. The-
re were no significant differences of LVEF, diastolic 
mitral flow VTI, mitral regurgitation flow VTI, and 
aortic valve flow VTI between RV sense triggered 
LV pacing and standard BiV pacing (p > 0.05). 
Figure 1 shows the ECG of a patient with dilated 
cardiomyopathy before treatment and after tre-
Table 1. The comparison of measurements between baseline, standard biventricular (BiV) pacing and 
right ventricular (RV) sense triggered left ventricular (LV) pacing (n = 30).
Measurements Prior to CRT Standard BiV pacing RV sense triggered LV pacing 
Atrioventricular delay [ms] 145.28 ± 5.69& 123.17 ± 5.55# 186.90 ± 7.36#*
QRS duration [ms] 152.93 ± 17.07 139.76 ± 11.73# 131.45 ± 7.48#*
LVEF [%] 26.86 ± 6.09 35.03 ± 5.08# 34.76 ± 5.30#
Mitral VTI 16.49 ± 1.14 18.69 ± 1.31# 18.42 ± 1.11#
Mitral regurgitation VTI 155.72 ± 23.07 135.62 ± 19.88# 137.07 ± 17.72#
Aortic VTI 17.20 ± 1.13 19.36 ± 1.06# 19.17 ± 1.14#
Time for optimization [min] – 55.6 ± 8.77 10.79 ± 4.02*
Average battery lifetime [yeas] – 4.25 ± 0.16 6.55 ± 0.35*
Average annual cost of the  
device use (thousand RMB)
– 21.2 ± 0.80 13.80 ± 0.70*
*p < 0.01 compared with standard BiV pacing; #p < 0.01 compared with prior to CRT; &PQ interval; CRT — cardiac resynchronization therapy; 
LVEF — left ventricular ejection fraction; VTI — velocity time integral; RMB — Ren Min Bi
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atment with standard BiV and pacing RV sense 
triggered LV pacing.
Subgroup analysis is displayed in Table 2 and 
the results showed that LVEF, mitral VTI, aortic 
VTI, and average battery lifetime under RV sense 
triggered LV pacing were significantly greater than 
those under the standard BiV pacing with RV pre-
-activation. QRS duration, mitral regurgitation flow 
VTI, time for optimization, and the average annual 
cost of the device use under RV sense triggered 
LV were significantly lower than those under the 
standard BiV pacing with RV pre-activation (p < 0.01 
or p < 0.05).
QRS duration, LVEF, mitral VTI, mitral re-
gurgitation flow VTI and aortic VTI between 
standard BiV pacing with LV pre-activation and RV 
sense triggered LV pacing are shown in Table 3. 
There were no significant differences for these 
parameters. Time for optimization and the average 
annual cost of the device use in RV sense triggered 
LV pacing were lower than those of standard BiV 
pacing with LV pacing pre-activation (p < 0.01). 
Average battery lifetime in RV sense triggered LV 
pacing was longer than that of standard BiV pacing 
with LV pacing pre-activation (p < 0.01).
In addition, the subgroup analysis showed that 
the acute hemodynamic effects of the RV sense 
triggered LV pacing were better than those of the 
standard BiV pacing after excluding the patients 
who need pacing the LV first.
Discussion
Chronic heart failure is one of the most com-
mon diseases with high mortality. Many studies 
have been conducted to investigate its clinical 
traits, mechanism, and therapy. The present study 
concentrated on the CRT with RV sense triggered 
LV pacing, and the difference of acute hemodyna-
mic effects between standard BiV pacing and RV 
sense trigged LV pacing. The subgroup analysis 
indicated that CRT with the RV sense trigged LV 
was superior to the standard BiV pacing with RV 
pre-activation.
Figure 1. Registration of 12-lead electrocardiogram of a patient with dilated cardiomyopathy: A. The patient was in 
sinus rhythm with complete left bundle branch block, and the QRS duration was 0.16 s prior to cardiac resynchroniza-
tion therapy implantation; B. Standard biventricular (BiV) pacing with VV delay of 10 ms (the optimized AV delay was 
130 ms, QRS duration was 0.14 s); C. Right ventricular sense triggered left ventricular pacing (the intrinsic PR interval 
was 200 ms, the sensed AV was set at 220 ms and QRS duration was 0.12 s which was significantly narrower than 
that of standard BiV pacing). The electrocardiograms on leads I, II, III, AVF, and V4–V6 showed that the stimulation was 
released at the beginning of R wave.
BA C
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Supraventricular pulses rapidly conduct 
through His-Purkinje system via AVN to activate 
ventricles. However, the pulses slowly conduct 
through cardiomyocytes and retrograde to the base 
of heart via His-Purkinje system along ventricular 
septum when pacing from RV apex. The changed 
activation sequence might cause the abnormality 
of the structure of cardiomyocytes, disarrangement 
of myocardial fibers, the damage of the structure of 
mitochondria, and myocardial calcification. These 
will influence the cell structure and ventricular 
geometry, and even the synchrony of ventricu-
lar contraction and relaxation. These variations 
might further harm the blood bump function of 
the ventricles. Therefore, minimized percentage 
of ventricular pacing (MVP) can decrease the risk 
of persistent atrial fibrillation [15]. In order to cap-
ture both ventricles during traditional CRT, AVD is 
often set to a relatively short value (100–120 ms) 
[16, 17]. Previous studies indicate that too short 
AVD will decrease the cardiac output of the patients 
with CHF, furthermore, the ventricular filling 
is more sufficient when AVD is programmed to 
200–250 ms. Under physiological condition, the 
optimal AVD might be affected by influence factors, 
such as exercise, sympathetic tone change and he-
art rate [11, 18, 19]. Generally, the PR interval will 
be prolonged 4 ms when the heart rate decreases 
every 10 beats in order to coordinate the function 
of atrium with ventricular filling. When there is no 
AV block [12], the intrinsic PR interval itself may be 
the optimal AVD. The cumbersome AVD optimization 
is unsuitable to perform at any time under the gui-
dance of echocardiography [20]. Therefore, setting 
appropriate AVD, encouraging AVN preference 
to promote the conduction through the right His-
Table 3. The comparison of measurements between standard biventricular (BiV) pacing with left ven-
tricular (LV) pacing pre-activation and right ventricular (RV) sense triggered LV pacing (n = 19).
Measurements Standard BiV pacing with LV pre-activation RV sense triggered LV pacing
Atrioventricular delay [ms] 124.20 ± 5.31 186.40 ± 6.96*
QRS duration [ms] 138.73 ± 14.57 134.07 ± 7.34
LVEF [%] 36.56 ± 4.79 32.09 ± 6.57#
Mitral VTI 19.30 ± 1.35 19.27 ± 0.90
Mitral regurgitation VTI 136.88 ± 19.55 153.78 ± 23.10#
Aortic VTI 19.88 ± 1.24 18.63 ± 1.45*
Time for optimization [min] 54.41 ± 8.40 9.70 ± 3.57*
Average battery lifetime [yeas] 4.26 ± 0.16 6.52 ± 0.36*
Average annual cost of the  
device use (thousand RMB)
21.10 ± 0.80 13.90 ± 0.70*
*p < 0.01 compared with LV pre-activation; #p < 0.05 compared with LV pre-activation; LVEF — left ventricular ejection fraction; VTI — velo-
city time integral; RMB — Ren Min Bi
Table 2. The comparison of measurements between standard biventricular (BiV) pacing with right ven-
tricular (RV) pacing pre-activation and RV sense triggered left ventricular (LV) pacing (n = 11).
Measurements Standard BiV pacing with RV pre-activation RV sense triggered LV pacing 
Atrioventricular delay [ms] 122.14 ± 5.79 187.14 ± 7.76*
QRS duration [ms] 140.79 ± 8.89 128.07 ± 2.73*
LVEF [%] 33.5 ± 5.37 37.43 ± 4.03#
Mitral VTI 18.11 ± 1.27 19.27 ± 1.32#
Mitral regurgitation VTI 134.36 ± 20.21 120.36 ± 12.34#
Aortic VTI 18.84 ± 0.88 19.71 ± 0.83#
Time for optimization [min] 56.79 ± 9.14 11.86 ± 4.47*
Average battery lifetime [yeas] 4.24 ± 0.16 6.58 ± 0.34*
Average annual cost of the  
device use (thousand RMB)
21.30 ± 0.80 13,70 ± 0.70*
*p < 0.01 compared with RV pre-activation; #p < 0.05 compared with RV pre-activation; LVEF — left ventricular ejection fraction; VTI — velo-
city time integral; RMB — Ren Min Bi
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-Purkinje system via dynamic intrinsic PR interval, 
and pacing LV simultaneously might meet the prin-
ciples of physiological pacing, and further improve 
the effectiveness of CRT in patients with LBBB.
Three-chamber pacemaker with VSR invented 
by Medtronic provides another solution for the 
patients who have a conduction of intrinsic rhythm 
(such as atrial fibrillation). CRT with RV sense 
triggering is the solution for LV pacing to attain 
CRT. In the present study, the results indicated 
that CRT could be realized by VSR pacing that 
sensed R wave by the electrodes located in the 
RV and trigger the LV pacing simultaneously when 
the intrinsic rhythms conduct to the RV. Thus, 
AVN preference was ensured and the principles 
of physiological pacing such as dynamic AVD and 
MVP were followed. In addition, since there was no 
need to pace the RV, the estimated battery lifetime 
was relatively extended and the average annual 
cost of the device use was indirectly decreased. 
Generally, the warranty period of the pacemaker 
under standard BiV pacing is 4 years. In this study, 
the battery lifetime could be extended to another 
2 years, and the average annual lifetime related 
costs of CRT device only could be decreased (from 
21200 RMB to 13800 RMB) under the RV sense 
triggered LV pacing (p < 0.01). However, many 
factors (such as artificial parameter and category 
of instrument) may affect the metrics of battery 
lifetime. Thus, a further investigation is needed 
to confirm this conclusion.
The activation sequence of the RV might be 
restored since the supraventricular pulses rapidly 
conduct to the RV under the RV sense triggered 
LV pacing. The time for RV activation was longer 
under the standard BiV pacing than that for the 
physiological activation because the activation was 
slowly conducted retrograde through cardiomyo-
cytes via His-Purkinje system, which manifests 
as longer QRS duration (p < 0.01). The former 
researches have proved that the abnormality of 
intraventricular conduction manifests as the exten-
sion of QRS duration and that the QRS duration is 
associated with mechanical dyssynchrony, i.e. the 
longer the QRS duration, the higher the percen-
tage of dyssynchrony, which means lower cardiac 
function and higher mortality [21]. The present 
study showed that RV sense triggered LV pacing 
may shorten the QRS duration in patients with 
CHF compared with standard BiV pacing. AV and 
VV interval optimization was time-consuming in 
standard BiV pacing, which generally took about 1 h 
every time and may increase the cost. Moreover, 
it was difficult to perform the optimization in pra-
ctice due to the effect of the position of patients, 
the angle of ultrasound probe, and the ability of 
technicians, which all lead to poor repeatability 
of the echocardiographic measurements. Thus, 
it was difficult to achieve individualization and 
dynamic optimization. In addition, the indicators 
and standards are still unclear [22, 23]. However, 
when the RV sense triggered LV pacing was pro-
grammed, the intrinsic PR interval itself might be 
the optimal AVD.
Limitations of the study
There were still some limitations to the pre-
sent study, such as the pacing of the RV was 
earlier than the LV to some extent under the RV 
sense triggered LV pacing. Moreover, the degree 
of advancement and the release of the stimulus for 
the LV depended on the slew rate of the RV elec-
trogram. Theoretically, patients who need pacing 
the LV first might not benefit from the RV sense 
triggered LV pacing. However, the previous studies 
found that about one-third of patients with CHF 
need pacing the RV first when the optimization of 
VV interval is performed [24]. The initial values 
of AV and VV are suggested to be programmed. 
Guidelines for AV and VV programming for CHF 
patients have been put forward [25, 26]. There was 
no significant difference of the acute hemodynamic 
effects between the RV sense triggered LV pacing 
and standard BiV pacing in this study. The reason 
might be related to a small sample size and inclu-
sion of the patients who need pacing the LV first.
The subgroup analysis showed that the acute 
hemodynamic effects of the RV sense triggered 
LV pacing were better than those of the standard 
BiV pacing after excluding the patients who need 
pacing the LV first. Thus, the optimal indication for 
the RV sense triggered LV pacing might be suited 
for patients who have no response to the standard 
BiV pacing and the patients who need pacing the 
RV first. The results of this study showed that 
the RV sense triggered LV pacing could improve 
acute hemodynamic effects of the patients with 
CHF compared with the standard BiV pacing. This 
algorithm might cause dispute between mainte-
nance and abolishment of the physiological AVD of 
AVN in current CRT, as well as even challenge to 
subvert the recommendation of 100% BiV pacing 
in current guidelines. However, a randomized, 
double blind, controlled clinical research approved 
by ethics committee is needed to compare the im-
provement of cardiac function and clinical outcome 
with respect to two different pacing modes in the 
next research.
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Conclusions
Right ventricular sense triggered LV provides 
benefits to CHF patients over standard CRT in 
terms of maintaining the physiological AVD of AVN 
and improving the acute hemodynamic effects.
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